7 completed. 7 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 7 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Fractures: new trials by email Literature Review of Fractures trials Research Report on Fractures
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bone Mass and Strength After Kidney Transplantation Vitamin D3, Calcitriol, Placebo - End Stage Renal Disease, Kidney Transplantation | Phase 2 | Completed | Columbia University | 61 | 2014-08-18 | 2025-03-07 |
| Musculoskeletal Effects of Bicarbonate potassium bicarbonate, Inactive placebo capsule - Muscle Loss, Fractures | Phase 2 | Completed | Tufts University | 244 | 2012-01-01 | 2015-10-19 |
| Low-magnitude High-frequency Vibration Study on Fracture Rate in Community Elderly Low-magnitude high-frequency vibration treatment - Fractures | Phase 2 / Phase 3 | Completed | Chinese University of Hong Kong | 704 | 2009-01-01 | 2012-04-24 |
| A Study of rhBMP-2/CPM in Closed Fractures of the Humerus rhBMP-2/CPM - Fractures | Phase 2 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 139 | 2007-01-01 | 2013-02-28 |
| Feasibility And Safety Study Of rhBMP-2/CPM For Hip Fractures rhBMP-2/CPM, surgical intervention alone - Fractures | Phase 2 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 108 | 2006-12-01 | 2013-02-28 |
| Clinical Evaluation of a Wireless Monitoring Device to Reduce Falls in the Elderly and Others at High Risk of Falling FallSaver (formerly called NOCwatch) - Accidental Falls, Fractures | Phase 1 / Phase 2 | Completed | NOCwatch International | 50 | 2004-12-01 | 2006-05-29 |
| Therapeutic Touch for Wrist Fractures in Postmenopausal Women Therapeutic Touch - Osteoporosis, Fractures | Phase 2 | Completed | National Center for Complementary and Integrative Health (NCCIH) | 125 | 2003-03-01 | 2006-08-17 |
Fractures, Bone (7) · Osteoporosis (2) · Bone Diseases, Metabolic (1) · Hyperparathyroidism (1) · Kidney Failure, Chronic (1) · Muscular Atrophy (1) · Vascular Calcification (1) · Wounds and Injuries (1)
Wounds and Injuries (6) · Bone Diseases (3) · Metabolic Diseases (3) · Musculoskeletal Diseases (3) · Nutritional and Metabolic Diseases (3) · Bone Diseases, Metabolic (2) · Pathological Conditions, Signs and Symptoms (2) · Atrophy (1) · Calcinosis (1) · Calcium Metabolism Disorders (1) · Chronic Disease (1) · Disease Attributes (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
Calcitriol (1) · Cholecalciferol (1) · Surgical Procedures, Operative (1) · Therapeutic Touch (1) · potassium bicarbonate (1)
Wyeth is now a wholly owned subsidiary of Pfizer (2) · Chinese University of Hong Kong (1) · Columbia University (1) · NOCwatch International (1) · National Center for Complementary and Integrative Health (NCCIH) (1) · Tufts University (1)
United States (6) · Australia (2) · Canada (2) · Finland (2) · France (2) · Germany (2) · Norway (2) · Sweden (2) · Brazil (1) · China (1) · Hungary (1) · Mexico (1) · Romania (1) · United Kingdom (1)
Bess Dawson-Hughes, M.D. (1) · Dennis Clifton, PharmD (1) · Karen M. Prestwood, MD (1) · Kathryn E Kelly, DrPH (1) · Kwok-Sui Leung, MD (1) · Thomas Nickolas, MD, MS (1)
PMID 24676848, PMID 28842733, PMID 29211866, PMID 35727196
R01AR060261 (1)